Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Survey Results Show High Symptom Burden in Early-Stage Breast Cancer Survivors

TON - August 2021 Vol 14, No 4 - Survivorship
William Ackerman

Hot flashes, fatigue, back and joint pain, and anxiety are some of the symptoms and concerns frequently reported by early-stage breast cancer survivors, according to results from a study of 98 women with low-risk stage I/II estrogen/progesterone-positive, HER2/neu-negative cancers. These findings were presented by Jessica Schumacher, PhD, MS, Associate Professor, Surgery, University of Wisconsin School of Medicine and Public Health, Madison, during the American Society of Breast Surgeons 22nd Annual Meeting.

According to Dr Schumacher, of the 3.5 million breast cancer survivors in the United States currently receiving follow-up care for detection of recurrence, symptom management, and treatment adherence, approximately two-thirds were diagnosed at an early stage and are at low risk for dying from their disease. Although many studies have reported on the symptom experience of survivors diagnosed with later-stage breast cancer, very few studies have focused on the post-treatment concerns of low-risk breast cancer survivors, she said.

Study Details

To assess how these symptoms interfered with the quality of life of survivors with early-stage breast cancer following active treatment, Dr Schumacher and colleagues surveyed patient-reported outcomes in women treated at the University of Wisconsin Breast Center. Survivors were eligible to participate if they had a history of stage I/II estrogen or progesterone receptor–positive, HER2/neu-negative breast cancer, were 6 months to 5 years postdiagnosis, were cancer-free, and had not received chemotherapy. Survey topics were shaped, in part, by the American Society of Clinical Oncology and the American Cancer Society Survivorship Care Guidelines.

The mean age of women surveyed was 61.3 years, and the average time from diagnosis was 2.5 years (range, 6 months-5 years). Lumpectomies had been performed in 71.3% of patients and mastectomies in 28.7%. Overall, 71% of patients were treated with breast-conserving surgery with radiotherapy, and 87.2% received endocrine therapy.

Clinically significant concerns were reported by 86.7% of women, with 38.8% citing 1 or 2 concerns, and 47.9% citing ≥3 concerns. Symptoms or concerns were absent altogether in 6.4% of women and clinically significant ones were absent in 13.8%.

“Physicians should be aware that breast cancer survivorship comes with a significant ongoing burden of symptoms, even for those who experience a mild form of the disease and do not receive aggressive treatment,” Dr Schumacher said.

Among patients reporting clinically significant symptoms or concerns, approximately 50% reported hot flashes, approximately 40% reported fatigue, and >30% reported back pain, joint pain, and anxiety. Headaches and difficulty taking endocrine therapy were reported by approximately 25% of respondents. Bone pain, new breast symptoms, cough, arm swelling, and extremity weakness were also relatively common complaints. In addition, some patients reported feeling anxious about the possibility of new symptoms, such as breast pain, that might indicate disease recurrence.

Dr Schumacher said that with approximately 50% of survivors reporting ≥3 concerns, it is likely that regular time-limited follow-up visits will not fully reveal them. For example, the complex and sensitive nature of concerns regarding sexual health were reflected in the fact that while on average only 2.0% of patients avoided responding to specific topics, 14.3% skipped sexual health questions, more than any other topic.

“This represents a clear opportunity to improve survivorship care,” Dr Schumacher stated.

“Our experience in developing this study suggests that a self-reported, pre-appointment assessment tool, such as the one used here, may be useful in helping physicians appropriately address patient concerns. It may alert them to symptoms with potential health implications and help physician visits focus on symptoms that are important to patients, providing a stimulus for meaningful discussions,” Dr Schumacher concluded.

Related Items
Cryoablation Safe and Effective in Patients with Low-Risk, Early-Stage Breast Cancer
William Ackerman
TON - August 2021 Vol 14, No 4 published on August 4, 2021 in Breast Cancer
Becoming Pregnant Is Feasible But Less Likely for Breast Cancer Survivors
Patricia Stewart
TON - June 2021 Vol 14, No 3 published on June 22, 2021 in Survivorship
Surgery Is a Viable Treatment Option for Patients with Early-Stage Germ Cell Tumors
Wayne Kuznar
TON - June 2020, Vol 13, No 3 published on June 16, 2020 in Survivorship
Call to Action: Greater Focus on Metastatic Cancer Survivors Is Needed
Eileen Koutnik-Fotopoulos
TON - August 2019, Vol 12, No 4 published on August 6, 2019 in Survivorship
Helping Patients, Caregivers, and Survivors Navigate Cancer Support Resources: The Art of Connecting People
Meg Barbor, MPH
TON - November 2018, Vol 11, No 5 published on November 28, 2018 in Survivorship
The Samfund Provides Financial Support for Young Adult Cancer Survivors
Meg Barbor, MPH
TON - September 2018, Vol 11, No 4 published on September 19, 2018 in Survivorship
Adherence to Exercise and Nutrition Guidelines Can Prolong Life in Cancer Survivors
Meg Barbor, MPH
TON - September 2018, Vol 11, No 4 published on September 19, 2018 in Survivorship
Improving Education for Nurse Practitioners Delivering Survivorship Care
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Survivorship
Maintaining Work and Productivity a Priority for Cancer Survivors
Meg Barbor, MPH
TON - July 2018, Vol 11, No 3 published on July 25, 2018 in Survivorship
Strategies to Address the Long-Term Financial Burden of Cancer in Survivors
Meg Barbor, MPH
TON - May 2018, Vol 11, No 2 published on May 15, 2018 in Financial/Insurance Information, Survivorship
Last modified: August 13, 2021